Pages that link to "Q44413664"
Jump to navigation
Jump to search
The following pages link to Evidence-based guidelines for cardiovascular disease prevention in women (Q44413664):
Displaying 50 items.
- 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines (Q22241919) (← links)
- AHA/ACC Guidelines for Secondary Prevention for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2006 Update (Q22252415) (← links)
- Partisan perspectives in the medical literature: a study of high frequency editorialists favoring hormone replacement therapy (Q24289488) (← links)
- Lipoprotein(a), hormone replacement therapy, and risk of future cardiovascular events (Q24629580) (← links)
- Juice powder concentrate and systemic blood pressure, progression of coronary artery calcium and antioxidant status in hypertensive subjects: a pilot study (Q24685582) (← links)
- Noninvasive Diagnostic Techniques for Coronary Disease in Women (Q27005921) (← links)
- Quality of cardiovascular disease preventive care and physician/practice characteristics (Q28196755) (← links)
- Gender differences across racial and ethnic groups in the quality of care for acute myocardial infarction and heart failure associated with comorbidities (Q28196762) (← links)
- Gender differences in cardiovascular disease and comorbid depression (Q28210846) (← links)
- Coronary artery disease in women: a review on prevention, pathophysiology, diagnosis, and treatment (Q28219423) (← links)
- Gender differences in aspirin use among adults with coronary heart disease in the United States (Q28220649) (← links)
- Preventing cardiovascular disease in women: an update (Q28221018) (← links)
- The therapeutic role of niacin in dyslipidemia management (Q28304559) (← links)
- Effects of a community-based healthy heart program on increasing healthy women's physical activity: a randomized controlled trial guided by Community-based Participatory Research (CBPR). (Q30363587) (← links)
- Effectiveness-based guidelines for the prevention of cardiovascular disease in women--2011 update: a guideline from the American Heart Association (Q30501645) (← links)
- Job strain and cardiovascular disease risk factors: meta-analysis of individual-participant data from 47,000 men and women (Q30654384) (← links)
- Are coronary event rates declining slower in women than in men - evidence from two population-based myocardial infarction registers in Finland? (Q30838080) (← links)
- Distribution, size, shape, growth potential and extent of abdominal aortic calcified deposits predict mortality in postmenopausal women (Q33743650) (← links)
- The heart truth professional education campaign on women and heart disease: needs assessment and evaluation results (Q33829386) (← links)
- Noninvasive Imaging to Evaluate Women With Stable Ischemic Heart Disease. (Q33841979) (← links)
- In Perspective: Estrogen Therapy Proves to Safely and Effectively Reduce Total Mortality and Coronary Heart Disease in Recently Postmenopausal Women (Q33862138) (← links)
- Outcomes of comprehensive heart care programs in high-risk women (Q34132138) (← links)
- Perimenopausal risk factors and future health (Q34184608) (← links)
- Raising HDL cholesterol in women. (Q34271942) (← links)
- Hormone replacement therapy is safe in women undergoing coronary artery bypass grafting (Q34315109) (← links)
- Low high-density lipoprotein cholesterol: current status and future strategies for management (Q34334846) (← links)
- Taking aim at HDL-C. Raising levels to reduce cardiovascular risk (Q34412708) (← links)
- A “window of opportunity:” The reduction of coronary heart disease and total mortality with menopausal therapies is age- and time-dependent (Q34612394) (← links)
- Distribution of 10-year and lifetime predicted risks for cardiovascular disease in US adults: findings from the National Health and Nutrition Examination Survey 2003 to 2006 (Q34683471) (← links)
- Management of dyslipidemia in women in the post-hormone therapy era. (Q34722828) (← links)
- Racial and Ethnic Patterns of Allostatic Load Among Adult Women in the United States: Findings from the National Health and Nutrition Examination Survey 1999–2004 (Q34784709) (← links)
- Physical activity, hormone replacement therapy, and the presence of coronary calcium in midlife women (Q34799103) (← links)
- Women at Risk for Coronary Heart Disease: How Research is Translated Into Innovation and Quality Outcomes at Kaiser Permanente. (Q35025637) (← links)
- Knowledge, preventive action, and barriers to cardiovascular disease prevention by race and ethnicity in women: an American Heart Association national survey (Q35086415) (← links)
- Causes of death and associated risk factors among climacteric women from Southern Brazil: a population based-study (Q35100170) (← links)
- Gender and sex: issues in medical education (Q35118070) (← links)
- Comparing costs associated with risk stratification rules for t-year survival (Q35204353) (← links)
- Trends in selected chronic conditions and behavioral risk factors among women of reproductive age, behavioral risk factor surveillance system, 2001-2009 (Q35565753) (← links)
- Vascular Aging across the Menopause Transition in Healthy Women (Q35610656) (← links)
- Risk factors for cardiovascular disease and hormone therapy in women (Q35771145) (← links)
- Review of the American Heart Association's guidelines for cardiovascular disease prevention in women (Q35771184) (← links)
- Acute coronary syndromes in women: is treatment different? Should it be? (Q35795315) (← links)
- Extended-release niacin/lovastatin: the first combination product for dyslipidemia (Q35821875) (← links)
- Coronary heart disease risk reduction in postmenopausal women: the role of statin therapy and hormone replacement therapy (Q35834128) (← links)
- Discontinuation of hormone replacement therapy after myocardial infarction and short term risk of adverse cardiovascular events: nationwide cohort study (Q35856372) (← links)
- Evaluating subject-level incremental values of new markers for risk classification rule (Q35924410) (← links)
- The clinical trial of Women On the Move through Activity and Nutrition (WOMAN) study (Q35928976) (← links)
- Sex/gender differences in cardiovascular disease prevention: what a difference a decade makes (Q35993886) (← links)
- Simvastatin plus ezetimibe: combination therapy for the management of dyslipidaemia (Q36040720) (← links)
- Gender differences in management and outcomes in patients with acute coronary syndromes: results on 20,290 patients from the AMIS Plus Registry (Q36057128) (← links)